ArticleDermatology research and practice2026
Outcomes of Electrosurgery Combined With 50% TCA Application in Patients With Rhinophyma.
Article in Dermatology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Outcomes of Electrosurgery Combined With 50% TCA Application in Patients With Rhinophyma.Dermatology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Rhinophyma causes significant cosmetic problems and social stigmatization. This study aimed to evaluate outcomes of electrosurgery combined with 50% trichloroacetic acid (TCA) treatment. Methods: The medical files and photographs of six patients who underwent rhinophyma electrosurgery combined with 50% TCA application were retrospectively analyzed. Demographic and clinical features of the patients, rhinophyma severity, posttreatment wound care, and treatment outcomes were reviewed. The cosmetic outcomes were evaluated with the physician's cosmetic evaluation scale and the patient's cosmetic satisfaction scale. Results: All six patients were male, with a mean age of 66.5 ± 3.5 years and a disease duration ranging from 3 to 21 years. The RHISI scores were 4 in two patients and 5 in four patients. All patients tolerated the whole process well. After electrosurgery, bismuth subgallate (BS) powder was poured for wound care. The BS coat remained until it dried and detached spontaneously from the skin after approximately 10 days. Subsequently, collagen gel was applied twice daily for 7-17 days. The mean time from the procedure day to the day of complete re-epithelialization was 24.0 ± 4.7 days. Only one patient had marked scarring on alar regions, one had no complications, and the remaining four had only minimal, nondisturbing skin changes in limited areas. Patients' cosmetic satisfaction scores ranged from 7 (satisfied) to 10 (extremely satisfied). Conclusion: Electrosurgery combined with 50% TCA application may provide a practical, well-tolerated, and low-cost treatment option in selected patients with rhinophyma. Postoperative wound care with topical BS powder and collagen gel serves a postoperative healing period of approximately three to 4 weeks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.